8-K: Sanuwave Health Announces $1.8 Million Private Placement and Warrant Issuance

Sanuwave Health, Inc. secures $1.8 million through a private placement involving convertible notes and warrants, alongside a separate promissory note.

Summary

• Sanuwave Health, Inc. has entered into a Securities Purchase Agreement for a private placement, raising $1.3 million through future advance convertible promissory notes.
• The company also issued warrants to purchase 32.5 million shares of common stock at $0.067 per share and another 32.5 million shares at $0.04 per share.
• The exercise price of the warrants is subject to adjustment based on future stock issuances or a Nasdaq listing, but will never be less than $0.01 per share.
• The warrants have a five-year term.
• The closing of the private placement occurred on June 18, 2024, with total proceeds of $1.8 million, including $0.5 million from a separate promissory note.
• The convertible notes have a conversion price of $0.04 per share, subject to adjustment, and bear interest at 15% per annum.
• The company also entered into a security agreement to secure its obligations under the notes, subordinate to the rights of NH Expansion Credit Fund Holdings LP.
• Sanuwave agreed to file a registration statement within 60 days to register the resale of shares issuable upon conversion of the notes and exercise of the warrants, aiming for effectiveness within 180 days.
• Purchasers waived the company's obligation to effect a reverse stock split by December 31, 2023, and agreed to receive shares in exchange for notes and warrants upon a reverse stock split or the closing of a business combination with SEP Acquisition Corp.
• A separate $0.5 million promissory note was issued to Manchester Explorer, L.P., bearing 15% interest and maturing on December 18, 2024.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. While the company has raised capital, there are risks associated with the terms of the financing and the company's ability to meet its obligations.

Positives

• The company successfully raised $1.8 million in funding through a private placement and a promissory note.
• The private placement includes warrants that could provide additional capital if exercised.
• The conversion price of the notes and the exercise price of the warrants are subject to adjustment, potentially benefiting investors.
• The company has a plan to register the resale of shares, providing liquidity to investors.

Negatives

• The conversion price of the notes and the exercise price of the warrants can be adjusted downwards, potentially diluting existing shareholders.
• The rights of the purchasers are subordinate to the rights of NH Expansion Credit Fund Holdings LP.
• The company is obligated to file a registration statement within a specific timeframe, which could be a burden.
• The company has a history of not meeting deadlines, as evidenced by the waiver of the reverse stock split obligation.

Risks

• The exercise price of the warrants and the conversion price of the notes are subject to adjustment, which could lead to dilution.
• The company's obligations under the notes are secured, which could impact the company's financial flexibility.
• The company's ability to meet the deadlines for filing the registration statement and achieving effectiveness is uncertain.
• The company's planned business combination with SEP Acquisition Corp. is subject to various conditions and may not be completed.

Future Outlook

The company plans to file a registration statement to allow for the resale of shares issued from the notes and warrants. The company also plans to complete a business combination with SEP Acquisition Corp.

Industry Context

The private placement and warrant issuance are common methods for small companies to raise capital. The company's focus on a business combination with a SPAC is also a trend in the current market.

Comparison to Industry Standards

• The terms of the convertible notes, including the 15% interest rate and the conversion price, are relatively standard for private placements in the current market.
• The warrant terms, including the exercise prices and the five-year term, are also typical for such transactions.
• The subordination of the notes to existing debt is a common practice in financing agreements.
• The company's obligation to file a registration statement is a standard requirement to provide liquidity to investors.

Related Party Transactions

• The promissory note was issued to Manchester Explorer, L.P., where Morgan Frank, the Chairman of the Company's Board of Directors and Chief Executive Officer, serves as a portfolio manager and a consultant.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Creditors may benefit from the security agreement and the interest payments on the notes.
• Employees may be impacted by the company's financial stability and future plans.
• Customers and suppliers may be indirectly affected by the company's financial decisions.

Next Steps

• The company will file a registration statement with the SEC to allow for the resale of shares issued from the notes and warrants.
• The company will continue to pursue its planned business combination with SEP Acquisition Corp.
• The company will need to manage its obligations under the notes and warrants, including potential adjustments to conversion and exercise prices.

Key Dates

Keywords

private placement, convertible notes, warrants, securities purchase agreement, registration rights, promissory note, capital raise, dilution, security agreement, subordination agreement